Back
Utah Medical Products Vs. Perspective Therapeutics Industry Stock Comparison
Sell
33
UTMD
Utah Medical Products
Last Price:
68.81
Seasonality Move:
5.9%
Buy
65
CATX
Perspective Therapeutics
Last Price:
1.75
Seasonality Move:
2.36%
Sell
33
Utah Medical Products (UTMD)
is a Sell
Is Utah Medical Products a Buy, Sell or Hold?
- The current Utah Medical Products [UTMD] share price is $68.74. The Score for UTMD is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- UTMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.75. The Score for CATX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UTMD Stock Price Chart
What is Utah Medical Products's stock price today?
-
The Utah Medical Products share price today is $68.74
The current trend is relatively stagnant and UTMD is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.75
The current trend is moderately bullish and CATX is experiencing slight buying pressure.
UTMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 51.28 | Buy |
| Chaikin Money Flow: | 631 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.91 - 69.61) | Buy |
| Bollinger Bands (100): | (67.59 - 80.23) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 61.6 | Buy |
| Chaikin Money Flow: | 980286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.49 - 1.75) | Buy |
| Bollinger Bands (100): | (0.59 - 1.47) | Buy |
UTMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.68 | Buy |
| 20-day SMA: | 67.84 | Buy |
| 50-day SMA: | 68.93 | Sell |
| 200-day SMA: | 80.25 | Sell |
| 8-day EMA: | 68.64 | Buy |
| 20-day EMA: | 68.37 | Buy |
| 50-day EMA: | 69.71 | Sell |
| 200-day EMA: | 78.16 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Sell |
| 20-day SMA: | 1.65 | Buy |
| 50-day SMA: | 1.4 | Buy |
| 200-day SMA: | 0.68 | Buy |
| 8-day EMA: | 1.76 | Sell |
| 20-day EMA: | 1.66 | Buy |
| 50-day EMA: | 1.42 | Buy |
| 200-day EMA: | 0.87 | Buy |
Utah Medical Products Earnings Growth & UTMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Utah Medical Products Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||